FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

People with stress-related inflammation likelier to suffer from depression Oct 21, 2:54 pm
Washington, Oct 21 (ANI): A new study has indicated that stress- related inflammation might lead to an increase in the risk of depression.
Full Story
Traffic pollution can harm lungs of babies in womb Oct 21, 1:07 pm
Washington, Oct 21 (ANI): A new study has found that exposure to pollution, especially during the second trimester of pregnancy, could harm a child's lungs.
Full Story
Worst-hit African nations receive vital supplies, resources to fight Ebola epidemic Oct 21, 12:04 pm
London, Oct 21 (ANI): Ghana President John Mahama has reportedly said that vital supplies and resources to tackle the Ebola outbreak are beginning to arrive in three worst-hit West African nations.
Full Story
People visiting doctors twice per yr likelier to have controlled BP Oct 21, 11:45 am
Washington, Oct 21 (ANI): A new research has revealed that visiting a doctor twice a year helps people to keep their blood pressure (BP) under control.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY